[Featured Stock] Green Cross MS Surges 25.8% Amid COVID-19 Increase
Green Cross MS is showing strong performance.
As of 10:04 AM on the 16th, Green Cross MS is trading at 6,390 KRW on the KOSDAQ market, up 1,310 KRW (25.79%) from the previous trading day.
It is interpreted that the recent sharp increase in the number of patients hospitalized due to COVID-19 is influencing the stock price.
Hot Picks Today
!["10 Million Won Grows to 2.18 Billion"... 'Father of ETFs' Recommends This Stock for Grandchildren [KOSPI 10,000 Era]](https://cwcontent.asiae.co.kr/asiaresize/93/2026072114592552828_1784613565.jpg)
"10 Million Won Grows to 2.18 Billion"... 'Father of ETFs' Recommends This Stock for Grandchildren [KOSPI 10,000 Era]
- "Don't Quit, We'll Give You a 50 Million Won Bonus"...This Company Takes Drastic Measures to Retain Talent
- Fired Over a $2 Snack: Why a 300 Million KRW Engineer Lost His Job
- Protect the 15% Tariff Cap... Minister Kim Jeong-gwan Heads to the U.S.
- "Joey Wong Returns After 22 Years: The Secret Behind Her Unchanging Beauty"
Green Cross MS was established in 2003 with the business purpose of manufacturing and selling in vitro diagnostic pharmaceuticals and medical devices, as well as manufacturing and selling pharmaceuticals and quasi-drugs.
![[Featured Stock] Green Cross MS Surges 25.8% Amid COVID-19 Increase](http://www.asiae.co.kr/news/img_view.htm?img=2024072208164559128_1721603806.jpg)
The company is composed of three business divisions: diagnostic reagents, hemodialysis solutions, and diabetes. By handling products in various fields together, it supplies to a wide range of customers including public health centers, screening centers, internal medicine clinics, dermatology clinics, plastic surgery clinics, hospitals, general hospitals, and university hospitals, thereby maintaining an extensive domestic sales network.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.
